About this event
From 1 October 2026, the NEW Libre 3 Plus will be available for ALL Australians living with type 1 diabetes via the NDSS subsidy.
Join the Libre team for a free online session to learn more about the world's smallest CGM sensor.*
What’s in store:
- Overview of the NEW Libre 3 Plus sensor
- How to use as a standalone sensor with the NEW Libre app
- Available automated insulin delivery (AID) integrations
- How to access Libre 3 Plus through the NDSS
Who is this session for? This session is best suited for people living with type 1 diabetes.
Date & Time: Wednesday 16 September, 7.00pm AEST.
Where: Online; join from anywhere in Australia.
Cost: Free
____________________
The FreeStyle Libre 3 Plus System is indicated for measuring interstitial fluid glucose levels in people (aged 2+) with diabetes. Finger pricks are required if your glucose readings and alarms do not match symptoms or expectations.
ALWAYS FOLLOW THE DIRECTIONS FOR USE. READ THE WARNINGS BEFORE PURCHASE. Find out more at FreeStyleLibre.com.au/.
* Compared to other on-market CGMs. As of August 2026.
Libre, FreeStyle, the butterfly logo, the sensor shape and appearance, the colour yellow, and related marks and/or designs are the intellectual property of the Abbott group of companies in various territories. Other marks are the property of their respective owners. Information contained herein is for distribution outside of the USA only. Abbott Australasia Pty. Ltd., Abbott Diabetes Care, 666 Doncaster Road, Doncaster, Victoria 3108, Australia. ABN 95 000 180 389. ADC-2698195 V2.0
Abbott
Abbott, Diabetes CareWe’re dedicated to helping people live more fully, in everything we do. We’re creating the future of healthcare through life-changing technologies and products that make you healthier and stronger, quickly identify when you have a medical need, and treat conditions to help get back to what you love.
